inclusion criteria: age 1. participant must be 19 to 55 years of age inclusive, at the time of signing the informed consent. type of participant and disease characteristics 2. participants who are healthy as determined by medical evaluation including medical history, physical examination, clinical laboratory tests, and medical judgement of the investigator 3. participants who are able to attend all scheduled visits and comply with all study procedures. weight 4. body mass index (bmi) within the range 18-30 kg/m2 at screening (inclusive) sex and contraceptive/barrier requirements 5. female participants of childbearing potential must agree to be heterosexually inactive, or agree to consistently use at least one acceptable method of contraception from at least 21 days prior to the 1st study vaccination to 8 weeks after the last study vaccination 6. female participants with a negative urine or serum pregnancy test at screening informed consent 7. capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: age 1. participant must be 19 to 55 years of age inclusive, at the time of signing the informed consent. type of participant and disease characteristics 2. participants who are healthy as determined by medical evaluation including medical history, physical examination, clinical laboratory tests, and medical judgement of the investigator 3. participants who are able to attend all scheduled visits and comply with all study procedures. weight 4. body mass index (bmi) within the range 18-30 kg/m2 at screening (inclusive) sex and contraceptive/barrier requirements 5. female participants of childbearing potential must agree to be heterosexually inactive, or agree to consistently use at least one acceptable method of contraception from at least 21 days prior to the 1st study vaccination to 8 weeks after the last study vaccination 6. female participants with a negative urine or serum pregnancy test at screening informed consent 7. capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: age participant must be 19 to 55 years of age inclusive, at the time of signing the informed consent. type of participant and disease characteristics participants who are healthy as determined by medical evaluation including medical history, physical examination, clinical laboratory tests, and medical judgement of the investigator participants who are able to attend all scheduled visits and comply with all study procedures. weight body mass index (bmi) within the range 18-30 kg/m2 at screening (inclusive) sex and contraceptive/barrier requirements female participants of childbearing potential must agree to be heterosexually inactive, or agree to consistently use at least one acceptable method of contraception from at least 21 days prior to the 1st study vaccination to 8 weeks after the last study vaccination female participants with a negative urine or serum pregnancy test at screening informed consent capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: age participant must be 19 to 55 years of age inclusive, at the time of signing the informed consent. type of participant and disease characteristics participants who are healthy as determined by medical evaluation including medical history, physical examination, clinical laboratory tests, and medical judgement of the investigator participants who are able to attend all scheduled visits and comply with all study procedures. weight body mass index (bmi) within the range 18-30 kg/m2 at screening (inclusive) sex and contraceptive/barrier requirements female participants of childbearing potential must agree to be heterosexually inactive, or agree to consistently use at least one acceptable method of contraception from at least 21 days prior to the 1st study vaccination to 8 weeks after the last study vaccination female participants with a negative urine or serum pregnancy test at screening informed consent capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: age 1. participant must be 19 to 55 years of age inclusive, at the time of signing the informed consent. type of participant and disease characteristics 2. participants who are healthy as determined by medical evaluation including medical history, physical examination, clinical laboratory tests, and medical judgement of the investigator 3. participants who are able to attend all scheduled visits and comply with all study procedures. weight 4. body mass index (bmi) within the range 18-30 kg/m2 at screening (inclusive) sex and contraceptive/barrier requirements 5. female participants of childbearing potential must agree to be heterosexually inactive, or agree to consistently use at least one acceptable method of contraception from at least 21 days prior to the 1st study vaccination to 8 weeks after the last study vaccination 6. female participants with a negative urine or serum pregnancy test at screening informed consent 7. capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: age 1. participant must be 19 to 55 years of age inclusive, at the time of signing the informed consent. type of participant and disease characteristics 2. participants who are healthy as determined by medical evaluation including medical history, physical examination, clinical laboratory tests, and medical judgement of the investigator 3. participants who are able to attend all scheduled visits and comply with all study procedures. weight 4. body mass index (bmi) within the range 18-30 kg/m2 at screening (inclusive) sex and contraceptive/barrier requirements 5. female participants of childbearing potential must agree to be heterosexually inactive, or agree to consistently use at least one acceptable method of contraception from at least 21 days prior to the 1st study vaccination to 8 weeks after the last study vaccination 6. female participants with a negative urine or serum pregnancy test at screening informed consent 7. capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.